IE
CGEM icon

Israel Englander’s Cullinan Oncology CGEM Stock Holding History

Israel Englander’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Hold
20,000
– – ﹤0.01% 4992
2026
Q1 		$284K Buy
+20,000
New +$257K ﹤0.01% 5029

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Israel Englander's CGEM Position: Q2 2026 in Review

Israel Englander reduced its Cullinan Oncology (CGEM) stake by 0.1% in Q2 2026, selling an estimated $5.2K and leaving 346,232 shares worth $6.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Israel Englander first reported a position in CGEM in Q1 2021 and has held it in 19 quarters since. The position peaked at $16.8M in Q1 2021. 182 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Israel Englander held 346,232 shares of Cullinan Oncology worth $6.3M as of Q2 2026.
  • Israel Englander sold 350 Cullinan Oncology shares in Q2 2026, an estimated $5.2K.
  • Cullinan Oncology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2773 holding.
  • Israel Englander first reported a position in Cullinan Oncology in Q1 2021 and has held it in 19 quarters since.
  • Israel Englander's Cullinan Oncology position peaked at $16.8M in Q1 2021.
  • 182 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.